Equities analysts expect Cardinal Health, Inc. (NYSE:CAH) to announce $32.84 billion in sales for the current quarter, Zacks Investment Research reports. Six analysts have issued estimates for Cardinal Health’s earnings. The lowest sales estimate is $32.11 billion and the highest is $33.38 billion. Cardinal Health reported sales of $31.38 billion in the same quarter last year, which indicates a positive year-over-year growth rate of 4.7%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, August 1st.

According to Zacks, analysts expect that Cardinal Health will report full year sales of $32.84 billion for the current fiscal year, with estimates ranging from $128.96 billion to $130.39 billion. For the next year, analysts forecast that the company will report sales of $138.54 billion per share, with estimates ranging from $136.71 billion to $140.53 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that that provide coverage for Cardinal Health.

Cardinal Health (NYSE:CAH) last released its earnings results on Monday, May 1st. The company reported $1.53 EPS for the quarter, beating the Zacks’ consensus estimate of $1.46 by $0.07. The company had revenue of $31.82 billion during the quarter, compared to analysts’ expectations of $32.30 billion. Cardinal Health had a return on equity of 25.78% and a net margin of 1.05%. The firm’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.43 EPS.

A number of brokerages recently issued reports on CAH. Vetr lowered Cardinal Health from a “hold” rating to a “sell” rating and set a $79.00 target price for the company. in a research note on Monday, February 27th. Needham & Company LLC began coverage on Cardinal Health in a research note on Tuesday, April 4th. They issued a “hold” rating for the company. Evercore ISI upgraded Cardinal Health to an “outperform” rating in a research note on Thursday, April 6th. Zacks Investment Research upgraded Cardinal Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday. Finally, ValuEngine lowered Cardinal Health from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Sixteen analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Cardinal Health currently has a consensus rating of “Hold” and a consensus target price of $82.64.

Cardinal Health (NYSE:CAH) opened at 79.68 on Friday. The stock has a market cap of $25.17 billion, a PE ratio of 19.02 and a beta of 0.80. The stock has a 50 day moving average price of $73.78 and a 200-day moving average price of $76.35. Cardinal Health has a 1-year low of $62.70 and a 1-year high of $85.52.

The firm also recently announced a quarterly dividend, which will be paid on Saturday, July 15th. Stockholders of record on Monday, July 3rd will be given a dividend of $0.4624 per share. The ex-dividend date of this dividend is Thursday, June 29th. This is a boost from Cardinal Health’s previous quarterly dividend of $0.45. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.32%. Cardinal Health’s dividend payout ratio (DPR) is 42.86%.

In other news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the firm’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the sale, the insider now directly owns 55,440 shares in the company, valued at approximately $4,039,912.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.94% of the stock is owned by company insiders.

Several large investors have recently bought and sold shares of CAH. Advisory Services Network LLC acquired a new stake in Cardinal Health during the first quarter worth approximately $120,000. Quadrant Capital Group LLC boosted its stake in Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock worth $156,000 after buying an additional 116 shares during the period. Northwest Quadrant Wealth Management LLC acquired a new stake in Cardinal Health during the fourth quarter worth approximately $173,000. Alpha Windward LLC boosted its stake in Cardinal Health by 1.8% in the first quarter. Alpha Windward LLC now owns 2,282 shares of the company’s stock worth $186,000 after buying an additional 41 shares during the period. Finally, MCF Advisors LLC boosted its stake in Cardinal Health by 11.5% in the first quarter. MCF Advisors LLC now owns 2,478 shares of the company’s stock worth $202,000 after buying an additional 256 shares during the period. Hedge funds and other institutional investors own 87.64% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Cardinal Health, Inc. (CAH) Expected to Announce Quarterly Sales of $32.84 Billion” was originally reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/06/24/cardinal-health-inc-cah-expected-to-announce-quarterly-sales-of-32-84-billion.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.